A Life-Critical Hedge Bet

VAP Diagnostics’ cholesterol test solves the 60 percent inaccuracy of standard tests. New investors bet this critical technology will flourish, after an earlier fumble by private equity.

Kenneth French, director of clinical operations at VAP Diagnostics, says VAP’s predecessor, Atherotech, had about 400 employees when it shut the doors, and VAP Diagnostics now has about 40. Re-establishing confidence with customers surprised by the interruption will take time, he says. Photos by Cary Norton It was about a year…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox